1 – 19 of 19
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis : What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses : A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel
(
- Contribution to journal › Article
- 2019
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2019 Update
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
(
- Contribution to journal › Article
- 2018
-
Mark
Updated European Association of Urology Guidelines : Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
(
- Contribution to journal › Letter
- 2017
-
Mark
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy.
(
- Contribution to journal › Scientific review
- 2015
-
Mark
EAU Guidelines on Renal Cell Carcinoma: 2014 Update.
(
- Contribution to journal › Article
-
Mark
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus.
2015) In European Urology(
- Contribution to journal › Scientific review
- 2013
-
Mark
Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels
(
- Contribution to journal › Article
-
Mark
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men : The PROBASE trial
(
- Contribution to journal › Article
- 2012
-
Mark
Rho Kinase (ROK)-Related Proteins in Human Cavernous Arteries: An Immunohistochemical and Functional Approach.
(
- Contribution to journal › Article
- 2011
-
Mark
Rho Kinase-related Proteins in Human Vaginal Arteries: An Immunohistochemical and Functional Study
(
- Contribution to journal › Article
-
Mark
Expression and Distribution of Phosphodiesterase Isoenzymes in the Human Seminal Vesicles.
(
- Contribution to journal › Article
- 2010
-
Mark
Expression and Distribution of Cyclic AMP- and Cyclic GMP-Binding Protein Kinases in the Human Vagina-An Immunohistochemical Study
(
- Contribution to journal › Article